Just to add, this is taken directly from the current Dimerix website:
So provided that there is a direct link to a reduction in proteinuria and improved quality of life, we could have a very good, safe alternative to all the other available drugs here, including the current SLGT2 Inhibitors.
I believe the FDA have already confirmed that reduction in proteinuria is an appropriate measure.
DMX200 competition including SGLT2 Inhibitors, page-2
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.015(4.11%) |
Mkt cap ! $211.7M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 39.0¢ | 36.5¢ | $822.1K | 2.156M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 174062 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 29612 | 1 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| DXB (ASX) Chart |